ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice [PDF]
Forsthoefel, D +7 more
core
Exploiting cellular senescence in hematologic malignancies. [PDF]
Jiang P +8 more
europepmc +1 more source
Mechanistic overview and suggested strategies to overcome BCL-2 inhibitor resistance in <i>TP53-</i>mutated acute myeloid leukemia. [PDF]
Iqbal U, Shallis RM.
europepmc +1 more source
Targeting signaling pathways in lymphoma: From molecular mechanisms to clinical breakthroughs. [PDF]
Wang S, Qiu Y, Zhao W.
europepmc +1 more source
<i>Listeria monocytogenes</i> invasion in goat brain tissues: mechanisms of blood-brain barrier disruption and regulation of apoptosis and autophagy. [PDF]
Hu Y +10 more
europepmc +1 more source
Signaling pathways and molecular mechanisms of lupeol in colorectal cancer: A comprehensive review. [PDF]
Farooqi MA, Sahu KK.
europepmc +1 more source
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia. [PDF]
Benrashid S, Woyach JA.
europepmc +1 more source
[Expression of Concern] Dexmedetomidine protects against sepsis‑associated encephalopathy through Hsp90/AKT signaling. [PDF]
Yin L, Chen X, Ji H, Gao S.
europepmc +1 more source
Cellular Effects and Regulated Protein Expression of MCF-7 Breast Cancer Cells Following Exposure to PAH Derivative 3-Hydroxybenz[a]anthracene. [PDF]
Kang X, Song W, Li X, Yang Y, Wu X.
europepmc +1 more source
Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL [PDF]
Adrian C. Newland +61 more
core +1 more source

